Know Labs, Inc. (KNW)
Market Cap | 24.88M |
Revenue (ttm) | n/a |
Net Income (ttm) | -16.90M |
Shares Out | 108.10M |
EPS (ttm) | -0.20 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 55,096 |
Open | 0.223 |
Previous Close | 0.230 |
Day's Range | 0.223 - 0.235 |
52-Week Range | 0.180 - 0.940 |
Beta | 1.56 |
Analysts | Buy |
Price Target | 1.00 (+334.41%) |
Earnings Date | Nov 15, 2024 |
About KNW
Know Labs, Inc., together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States. The company’s proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was incorporated in ... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to one analyst, the rating for KNW stock is "Buy" and the 12-month stock price forecast is $1.0.
News
Know Labs Provides Overview of FY2024 10-K Annual Report
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive diagnostics technology released this morning an overview of its Form 10-K annual report for its fisc...
Know Labs, Inc. Announces Receipt of Audit Opinion with Going Concern Explanation
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), leading developer of non-invasive diagnostics technology, today announced that, as previously disclosed in its Annual Report on Form 10-...
Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2024 Results
SEATTLE--(BUSINESS WIRE)--Know Labs, an emerging developer of non-invasive medical diagnostic technology, reported financial results for the Q4 and fiscal year of 2024.
Know Labs Announces Expanded Technology Leadership in its Executive Team
SEATTLE--(BUSINESS WIRE)--Know Labs Announces Expanded Technology Leadership in its Executive Team; Acceleration of Platform Development to Secure Strategic Partnerships.
Know Labs Sensor Technology in Steering Wheels Could Curb Impaired Driving
SEATTLE--(BUSINESS WIRE)--Know Labs Sensor Technology in Steering Wheels Could Curb Impaired Driving. Know Labs Retains Stanbridge Group to Secure Automotive JV Partnerships.
Know Labs Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
SEATTLE--(BUSINESS WIRE)--Know Labs Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards. A Plan for Compliance has been undertaken.
Know Labs Study Published in IEEE Sensors Journal
SEATTLE--(BUSINESS WIRE)--Peer-reviewed journal publication validates Know Labs' proprietary technology and its application for non-invasive blood glucose monitoring.
Know Labs, Inc. Announces $1.655 Million Public Offering
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW) (the “Company”), a leading developer of non-invasive medical diagnostic technology, today announced that it has entered into definitive a...
Know Labs, Inc. (KNW) Q3 2024 Earnings Call Transcript
Know Labs, Inc. (NYSE:KNW) Q3 2024 Results Earnings Conference Call August 14, 2024 4:30 PM ET Company Participants Ron Erickson - Chairman and Chief Executive Officer Peter Conley - Chief Financial ...
Know Labs, Inc. Reports Third Quarter FY 2024 Results
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today reported financial results for the third quarter of the fiscal ...
Know Labs, Inc. Announces Closing of $3.445 Million Public Offering
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostics technology, today announced the successful closing of its previously announced u...
Know Labs, Inc. Announces Pricing of $3.445 Million Public Offering
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW) (the “Company”), a leading developer of non-invasive medical diagnostic technology, today announced the pricing of a firm commitment unde...
Sandbox VR Opens First Australian Location August 15 in Gold Coast
BRISBANE, Australia--(BUSINESS WIRE)--Sandbox VR, a full-body virtual reality entertainment experience, is pleased to announce the grand opening of its first Australian location on Thursday, August 15...
Know Labs, Inc. to Host Review of Third Quarter Fiscal Year 2024 Results on August 14, 2024
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates and...
Know Labs Publishes Clinical Results in Leading Diabetes Journal
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today announced the publication of its peer-reviewed study in Diabete...
Know Labs to Present at the American Diabetes Association's Scientific Sessions
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today announced further interim results from a clinical research stud...
Know Labs Joins the Industrial Participant Program of the Wyss Institute for Biologically Inspired Engineering at Harvard University
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today announced that it has joined the Industrial Participant Program...
Know Labs Appoints Chris Somogyi as President, International
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging leader in non-invasive medical diagnostic technology, today announced the appointment of Chris Somogyi as President, Interna...
Know Labs, Inc. (KNW) Q2 2024 Earnings Call Transcript
Know Labs, Inc. (NYSE:KNW) Q2 2024 Earnings Conference Call May 15, 2024 4:30 PM ET Company Participants Jordyn Hujar - Chief of Staff Ron Erickson - Chief Executive Officer Peter Conley - Chief Fina...
Know Labs, Inc. Reports Second Quarter FY 2024 Results
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today reported financial results for the second quarter of the fiscal...
Know Labs to Present Clinical Research at the 2024 American Association of Clinical Endocrinology Annual Meeting
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has been selected for an oral abstract presentat...
Know Labs, Inc. to Host Review of Second Quarter Fiscal Year 2024 Results on May 15, 2024
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates a...
Know Labs to Present Clinical Research at the 2024 American Physiology Summit
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has been selected for an abstract poster present...
Know Labs' Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research Study
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced interim results from its most recent clinical resea...
Know Labs Secures U.S. $12 Million Funding for Company's Further Execution on Its Clinical Research and Development Initiatives
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has entered into a funding agreement for an inve...